Hester Biosciences Ltd - Stock Valuation and Financial Performance

BSE: 524669 | NSE: HESTERBIO | Pharmaceuticals & Drugs | Small Cap

Hester Biosciences Share Price

2,370.15 -12.35 -0.52%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Hester Biosciences

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Semi Strong

Hester Biosciences stock performance -

mw4me loader
P/E Ratio (SA):
63.66
Market Cap:
2,016.3 Cr.
52-wk low:
1,292.9
52-wk high:
3,375.5

Is Hester Biosciences Ltd an attractive stock to invest in?

1. Is Hester Biosciences Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Hester Biosciences Ltd is a good quality company.

2. Is Hester Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Hester Biosciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Hester Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Hester Biosciences Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Hester Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hester Biosciences Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 19.9%21.8%24.2%26.3%31.2%19.7%23.3%17.3%11.9%9.3%-
Value Creation
Index
0.40.60.70.91.20.40.70.2-0.2-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 90101123135171169208219254285285
Sales YoY Gr.-12.1%22.2%9.3%27%-1%23.1%5.2%15.8%12.3%-
Adj EPS 14.222.829.335.850.935.751.645.436.931.537.2
YoY Gr.-60.9%28.7%22%42.4%-29.8%44.3%-11.9%-18.7%-14.6%-
BVPS (₹) 99117.9143.5171.7210.9238.7279.3315.5343.7367.6382.5
Adj Net
Profit
1219.424.930.443.330.443.938.631.426.832
Cash Flow from Ops. 20.418.627.632.336.225.841.115.933.442.8-
Debt/CF from Ops. 1.92.11.41.31.11.90.47.74.93.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 13.7%10.7%11%12.3%
Adj EPS 9.3%-9.1%-15.1%-14.6%
BVPS15.7%11.8%9.6%7%
Share Price 21.1% 9.7% -2.4% 62.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
152122.422.726.615.919.915.311.28.99.9
Op. Profit
Mgn %
28.533.433.436.839.731.134.727.621.516.418.3
Net Profit
Mgn %
13.419.220.222.625.3182117.612.49.411.1
Debt to
Equity
0.50.40.30.30.20.20.10.50.60.40.2
Working Cap
Days
231229217220208261245279292271128
Cash Conv.
Cycle
16316014014013416414516416815163

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 11.00%

Return on Equity has declined versus last 3 years average to 9.90%

Net Profit has been subdued in last 3 years -15.12%

Sales growth is not so good in last 4 quarters at 3.67%

Latest Financials - Hester Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 37.2 27.6
TTM Sales (₹ Cr.) 285 312
BVPS (₹.) 382.5 354.8
Reserves (₹ Cr.) 322 293
P/BV 6.20 6.68
PE 63.66 85.91
From the Market
52 Week Low / High (₹) 1292.90 / 3375.45
All Time Low / High (₹) 0.25 / 3375.45
Market Cap (₹ Cr.) 2,016
Equity (₹ Cr.) 8.5
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Hester Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Hester Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales90101123135171169208219254285
Operating Expenses 64678285103117136159199238
Manufacturing Costs14141215181918192028
Material Costs252030232929536480100
Employee Cost 12151822273733394857
Other Costs 14192225293232375154
Operating Profit 26334150685372615547
Operating Profit Margin (%) 28.5%33.1%33.3%36.8%39.6%31.1%34.5%27.6%21.5%16.4%
Other Income 0112332565
Interest 4432454265
Depreciation 56658910101010
Exceptional Items 300000-5000
Profit Before Tax 19253344604155534437
Tax 56813161015141210
Profit After Tax 14192531443140403227
PAT Margin (%) 15.5%19.1%20.2%22.7%25.6%18.4%19.1%18.0%12.7%9.5%
Adjusted EPS (₹)16.522.629.335.951.636.746.946.538.031.9
Dividend Payout Ratio (%)19%18%18%28%21%18%21%22%21%19%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 84100122146179203238268292313
Share Capital 9999999999
Reserves 7692114138171195229260284304
Minority Interest0000000000
Debt3634363932394107141109
Long Term Debt151319151173738379
Short Term Debt2021182421322335730
Trade Payables567881414112930
Others Liabilities 16191318202126388498
Total Liabilities 140159178210240277282424546550

Fixed Assets

Gross Block94105110121162167165171199204
Accumulated Depreciation384349546170788791100
Net Fixed Assets57626167101978784108103
CWIP 1410213001482149171
Investments 99914284144656565
Inventories29343339486057717969
Trade Receivables18262732334546578286
Cash Equivalents 451112251265
Others Assets9131616272844645751
Total Assets 140159178210240277282424546550

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 20192832362641163343
PBT 19253344604155534437
Adjustment 799781220121513
Changes in Working Capital -0-10-7-9-16-16-20-33-174
Tax Paid -5-6-7-9-16-11-13-16-8-11
Cash Flow From Investing Activity -12-6-15-26-25-21-4-111-72-21
Capex -8-60-21-12-7-4-90-73-22
Net Investments 0000-1-21-2000
Others -40-16-5-12-12-1002
Cash Flow From Financing Activity -5-12-6-6-20-1-419541-24
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 8-26-4-3-1-27312-3
Interest Paid -4-4-3-2-4-4-4-1-10-13
Dividend Paid -2-5-4-6-10-7-6-9-9-7
Others -7-1-47-311-303248-2
Net Cash Flow 3160-93-403-2
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)17.4720.8322.4322.7926.9416.3318.1115.6211.538.98
ROCE (%)19.8521.7924.1626.2831.1519.7423.2817.3111.919.26
Asset Turnover Ratio0.690.690.740.70.760.650.750.630.530.52
PAT to CFO Conversion(x)1.4311.121.030.820.841.030.41.031.59
Working Capital Days
Receivable Days637877796983798599108
Inventory Days12811197979311710310510794
Payable Days67978112099135947291108

Hester Biosciences Ltd Stock News

Hester Biosciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Hester Biosciences on 20-Dec-2024 16:59 is ₹2,370.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Hester Biosciences stood at ₹2,016.3.
The latest P/E ratio of Hester Biosciences as of 20-Dec-2024 16:59 is 63.66.
The latest P/B ratio of Hester Biosciences as of 20-Dec-2024 16:59 is 6.20.
The 52-week high of Hester Biosciences is ₹3,375.5 and the 52-week low is ₹1,292.9.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hester Biosciences is ₹285.4 ( Cr.) .

About Hester Biosciences Ltd

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.

Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes – A, B & C.

Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.

Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.

Product range of the company includes:

  • Live Vaccines
  • Killed Vaccines
  • Diagnostic kits &  Seromonitoring services

Achievements/ recognition:

  • GMP and ISO 9001:2000 certified company
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.